These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 28886713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
    Li L, He J, Zhu L, Yang Y, Jin Y, Jia R, Liu X, Liu Y, Sun X, Li Z.
    J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
    Alunno A, Petrillo MG, Nocentini G, Bistoni O, Bartoloni E, Caterbi S, Bianchini R, Baldini C, Nicoletti I, Riccardi C, Gerli R.
    Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development.
    Milger K, Yu Y, Brudy E, Irmler M, Skapenko A, Mayinger M, Lehmann M, Beckers J, Reichenberger F, Behr J, Eickelberg O, Königshoff M, Krauss-Etschmann S.
    Thorax; 2017 Nov; 72(11):1007-1020. PubMed ID: 28780502
    [Abstract] [Full Text] [Related]

  • 13. The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome.
    Sarigul M, Yazisiz V, Bassorgun CI, Ulker M, Avci AB, Erbasan F, Gelen T, Gorczynski RM, Terzioglu E.
    Lupus; 2010 Feb; 19(2):138-45. PubMed ID: 19952070
    [Abstract] [Full Text] [Related]

  • 14. Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis.
    Bennett D, Bargagli E, Bianchi N, Landi C, Fossi A, Fui A, Sestini P, Refini RM, Rottoli P.
    Respir Physiol Neurobiol; 2020 Feb; 273():103323. PubMed ID: 31678459
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
    Furuzawa-Carballeda J, Sánchez-Guerrero J, Betanzos JL, Enriquez AB, Avila-Casado C, Llorente L, Hernández-Molina G.
    Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M, Bonella F, He X, Sixt SU, Sarria R, Guzman J, Costabel U.
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.